Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BUZAID AC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buzaid, AC; Atkins, M
      Practical guidelines for the management of biochemotherapy-related toxicity in melanoma

      CLINICAL CANCER RESEARCH
    2. Balch, CM; Buzaid, AC; Soong, SJ; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Gershenwald, JE; Houghton, A; Kirkwood, JM; McMasters, KM; Mihm, MF; Morton, DL; Reintgen, DS; Ross, MI; Sober, A; Thompson, JA; Thompson, JF
      Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    3. Ekmekcioglu, S; Ellerhorst, J; Smid, CM; Prieto, VG; Munsell, M; Buzaid, AC; Grimm, EA
      Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival

      CLINICAL CANCER RESEARCH
    4. Grimm, EA; Smid, CM; Lee, JJ; Tseng, CH; Eton, O; Buzaid, AC
      Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy

      CLINICAL CANCER RESEARCH
    5. Gershenwald, JE; Buzaid, AC; Ross, MI
      Classification and staging of melanoma

      CLINICS IN LABORATORY MEDICINE
    6. Gershenwald, JE; Fischer, D; Buzaid, AC
      Clinical classification and staging

      CLINICS IN PLASTIC SURGERY
    7. Eton, O; Buzaid, AC; Bedikian, AY; Smith, TM; Papadopoulos, NE; Ellerhorst, JA; Hibberts, JL; Legha, SS; Benjamin, RS
      A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

      CANCER
    8. Balch, CM; Buzaid, AC; Atkins, MB; Cascinelli, N; Coit, DG; Fleming, ID; Houghton, A; Kirkwood, JM; Mihm, MF; Morton, DL; Reintgen, D; Ross, MI; Sober, A; Soong, SJ; Thompson, JA; Thompson, JF; Gershenwald, JE; McMasters, KM
      A new American Joint Committee on Cancer staging system for cutaneous melanoma

      CANCER
    9. Ellerhorst, JA; Bedikian, A; Ring, S; Buzaid, AC; Eton, O; Legha, SS
      Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy

      ONCOLOGY REPORTS
    10. Ekmekcioglu, S; Okcu, MF; Colome-Grimmer, MI; Owen-Schaub, L; Buzaid, AC; Grimm, EA
      Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10

      MELANOMA RESEARCH
    11. Bedikian, AY; Legha, SS; Eton, O; Buzaid, AC; Papadopoulos, N; Plager, C; McIntyre, S; Viallet, J
      Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma

      ANTI-CANCER DRUGS
    12. Poo-Hwu, WJ; Ariyan, S; Lamb, L; Papac, R; Zelterman, D; Hu, GL; Brown, J; Fischer, D; Bolognia, J; Buzaid, AC
      Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma

      CANCER
    13. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    14. ETON O; KHARKEVITCH DD; GIANAN MA; ROSS MI; ITOH K; PRIDE MW; DONAWHO C; BUZAID AC; MANSFIELD PF; LEE JE; LEGHA SS; PLAGER C; PAPADOPOULOS NE; BEDIKIAN AY; BENJAMIN RS; BALCH CM
      ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA

      Clinical cancer research
    15. BUZAID AC; ALIOSMAN F; AKANDE N; GRIMM EA; LEE JJ; BEDIKIAN A; ETON O; PAPADOPOULOS N; PLAGER C; LEGHA SS; BENJAMIN RS
      DNA-DAMAGE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CORRELATES WITH RESPONSE TO BIOCHEMOTHERAPY IN MELANOMA

      Melanoma research
    16. ANDERSON CM; BUZAID AC; SUSSMAN J; LEE JJ; ALIOSMAN F; BRAUNSCHWEIGER PG; PLAGER C; BEDIKIAN A; PAPADOPOULOS N; ETON O; LEGHA SS; GRIMM EA
      NITRIC-OXIDE AND NEOPTERIN LEVELS AND CLINICAL-RESPONSE IN STAGE-III MELANOMA PATIENTS RECEIVING CONCURRENT BIOCHEMOTHERAPY

      Melanoma research
    17. Buzaid, AC; Colome, M; Bedikian, A; Eton, O; Legha, SS; Papadopoulos, N; Plager, C; Ross, M; Lee, JE; Mansfield, P; Rice, J; Ring, S; Lee, JJ; Strom, E; Benjamin, R
      Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases

      MELANOMA RESEARCH
    18. GERSHENWALD JE; BUZAID AC; ROSS MI
      CLASSIFICATION AND STAGING OF MELANOMA

      Hematology/oncology clinics of North America
    19. LEGHA SS; RING S; ETON O; BEDIKIAN A; BUZAID AC; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA

      Journal of clinical oncology
    20. ETON O; LEGHA SS; MOON TE; BUZAID AC; PAPADOPOULOS NE; PLAGER C; BURGESS AM; BEDIKIAN AY; RING S; DONG Q; GLASSMAN AB; BALCH CM; BENJAMIN RS
      PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA

      Journal of clinical oncology
    21. FRUEHAUF JP; ZONIS S; ALBASSAM M; KYSHTOOBAYEVA A; DASGUPTA C; MILOVANOVIC T; PARKER RJ; BUZAID AC
      MELANIN CONTENT AND DOWN-REGULATION OF GLUTATHIONE-S-TRANSFERASE CONTRIBUTE TO THE ACTION OF L-BUTHIONINE-S-SULFOXIMINE ON HUMAN-MELANOMA

      Chemico-biological interactions
    22. RAAD II; HACHEM RY; ABISAID D; ROLSTON KVI; WHIMBEY E; BUZAID AC; LEGHA S
      A PROSPECTIVE CROSSOVER RANDOMIZED TRIAL OF NOVOBIOCIN AND RIFAMPIN PROPHYLAXIS FOR THE PREVENTION OF INTRAVASCULAR CATHETER INFECTIONS IN CANCER-PATIENTS TREATED WITH INTERLEUKIN-2

      Cancer
    23. SCHULTZ MZ; BUZAID AC; POO WJ
      A PHASE-II STUDY OF INTERFERON-ALPHA-2B WITH DACARBAZINE, CARMUSTINE,CISPLATIN AND TAMOXIFEN IN METASTATIC MELANOMA

      Melanoma research
    24. BEDIKIAN AY; LEGHA SS; ETON O; BUZAID AC; PAPADOPOULOS N; COATES S; SIMMONS T; NEEFE J; VONROEMELING R
      PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA

      Annals of oncology
    25. FRUEHAUF JP; ZONIS S; ALBASSAM M; KYSHTOOBAYEVA A; DASGUPTA C; MILOVANOVIC T; PARKER RJ; BUZAID AC
      SELECTIVE AND SYNERGISTIC ACTIVITY OF L-S,R-BUTHIONINE SULFOXIMINE ONMALIGNANT-MELANOMA IS ACCOMPANIED BY DECREASED EXPRESSION OF GLUTATHIONE-S-TRANSFERASE

      Pigment cell research
    26. JUNG FA; BUZAID AC; ROSS MI; WOODS KV; LEE JJ; ALBITAR M; GRIMM EA
      EVALUATION OF TYROSINASE MESSENGER-RNA AS A TUMOR-MARKER IN THE BLOODOF MELANOMA PATIENTS

      Journal of clinical oncology
    27. BUZAID AC
      CUTANEOUS MELANOMA, STAGING SYSTEM - REPLY

      Journal of clinical oncology
    28. BUZAID AC; ROSS MI; BALCH CM; SOONG SJ; MCCARTHY WH; TINOCO L; MANSFIELD P; LEE JE; BEDIKIAN A; ETON O; PLAGER C; PAPADOPOULOS N; LEGHA SS; BENJAMIN RS
      CRITICAL ANALYSIS OF THE CURRENT AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM FOR CUTANEOUS MELANOMA AND PROPOSAL OF A NEW STAGING SYSTEM

      Journal of clinical oncology
    29. SPORN JR; BUZAID AC; SLATER D; COHEN N; GREENBERG BR
      TREATMENT OF ADVANCED PANCREATIC ADENOCARCINOMA WITH 5-FU, LEUCOVORIN, INTERFERON-ALPHA-2B, AND CISPLATIN

      American journal of clinical oncology
    30. FRANCIS GM; KROHN EG; WOODS KV; BUZAID AC; GRIMM EA
      INTERLEUKIN-6 PRODUCTION AND SECRETION IN HUMAN-MELANOMA CELL-LINES -REGULATION BY INTERLEUKIN-1

      Melanoma research
    31. LEGHA SS; RING S; BEDIKIAN A; PLAGER C; ETON O; BUZAID AC; PAPADOPOULOS N
      TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA

      Annals of oncology
    32. BALCH CM; BUZAID AC
      FINALLY, A SUCCESSFUL ADJUVANT THERAPY FOR HIGH-RISK MELANOMA

      Journal of clinical oncology
    33. MURREN JR; DURIVAGE HJ; BUZAID AC; REISS M; FLYNN SD; CARTER D; HAIT WN
      TRIFLUOPERAZINE AS A MODULATOR OF MULTIDRUG-RESISTANCE IN REFRACTORY BREAST-CANCER

      Cancer chemotherapy and pharmacology
    34. JUNG FA; BUZAID AC; WOODS KV; ROSS M; GRIMM EA
      DETECTION OF MELANOMA-CELLS IN PERIPHERAL-BLOOD USING REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION ASSAY FOR TYROSINASE MESSENGER-RNA

      Cancer surveys
    35. BUZAID AC; BALCH CM
      POLYMERASE CHAIN-REACTION FOR DETECTION OF MELANOMA IN PERIPHERAL-BLOOD - TOO EARLY TO ASSESS CLINICAL-VALUE

      Journal of the National Cancer Institute
    36. BUZAID AC; TINOCO LA; JENDIROBA D; TU ZN; LEE JJ; LEGHA SS; ROSS MI; BALCH CM; BENJAMIN RS
      PROGNOSTIC VALUE OF SIZE OF LYMPH-NODE METASTASES IN PATIENTS WITH CUTANEOUS MELANOMA

      Journal of clinical oncology
    37. BUZAID AC; TINOCO L; ROSS MI; LEGHA SS; BENJAMIN RS
      ROLE OF COMPUTED-TOMOGRAPHY IN THE STAGING OF PATIENTS WITH LOCAL-REGIONAL METASTASES OF MELANOMA

      Journal of clinical oncology
    38. BEDIKIAN AY; WEISS GR; LEGHA SS; BURRIS HA; ECKARDT JR; JENKINS J; ETON O; BUZAID AC; SMETZER L; VONHOFF DD; BENJAMIN RS
      PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY

      Journal of clinical oncology
    39. BUZAID AC; PIZZORNO G; MARSH JC; RAVIKUMAR TS; MURREN JR; TODD M; STRAIR RK; POO WJ; HAIT WN
      BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY

      Cancer chemotherapy and pharmacology
    40. ANDERLINI P; BUZAID AC; LEGHA SS
      ACUTE RHABDOMYOLYSIS AFTER CONCURRENT ADMINISTRATION OF INTERLEUKIN-2, INTERFERON-ALFA, AND CHEMOTHERAPY FOR METASTATIC MELANOMA

      Cancer
    41. BUZAID AC; GRIMM EA; ALIOSMAN F; RING S; ETON O; PAPADOPOULOS NE; BEDIKIAN A; PLAGER C; LEGHA SS; BENJAMIN R
      MECHANISM OF THE ANTITUMOR EFFECT OF BIOCHEMOTHERAPY IN MELANOMA - PRELIMINARY-RESULTS

      Melanoma research
    42. BUZAID AC; SANDLER AB; HAYDEN CL; SCINTO J; POO WJ; CLARK MB; HOTCHKISS S
      NEURON-SPECIFIC ENOLASE AS A TUMOR-MARKER IN METASTATIC MELANOMA

      American journal of clinical oncology
    43. MURREN JR; DURIVAGE HJ; ROSENBERG AH; CHEN YT; DELPRETE SA; MURPHY GJ; BUZAID AC; HAIT WN
      CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN

      American journal of clinical oncology
    44. BUZAID AC; LEGHA SS
      COMBINATION OF CHEMOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA FOR THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology
    45. BUZAID AC; LEGHA SS; BALCH CM; ROSS M; RING S; PLAGER C; PAPADOPOULOS NE; ELNAGGAR AK; BENJAMIN RS
      PILOT-STUDY OF PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE,AND DACARBAZINE IN PATIENTS WITH LOCAL-REGIONAL RECURRENCE OF MELANOMA

      Cancer
    46. BUZAID AC; LEGHA SS; BALCH CM; ROSS M; RING S; PLAGER C; PAPADOPOULOS NE; ELNAGGAR AK; BENJAMIN RS
      PILOT-STUDY OF PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE,AND DACARBAZINE IN PATIENTS WITH LOCAL-REGIONAL RECURRENCE OF MELANOMA

      Cancer
    47. MURREN JR; GANPULE S; PAPAC R; SON YH; PESCHEL RE; DURIVAGE H; BUZAID AC; LAMB L; MAKUCH R; HAIT WN
      A PHASE-II TRIAL OF MITOMYCIN-C, 5-FLUOROURACIL AND RADIATION-THERAPYIN THE TREATMENT OF UNRESECTABLE NONSMALL CELL LUNG-CANCER

      Oncology research
    48. LEGHA SS; BUZAID AC
      ROLE OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFAAND CHEMOTHERAPY IN THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 21:24:34